ロード中...
Targeting the ubiquitin‐proteasome system in a pancreatic cancer subtype with hyperactive MYC
The myelocytomatosis oncogene (MYC) is an important driver in a subtype of pancreatic ductal adenocarcinoma (PDAC). However, MYC remains a challenging therapeutic target; therefore, identifying druggable synthetic lethal interactions in MYC‐active PDAC may lead to novel precise therapies. First, to...
保存先:
| 出版年: | Mol Oncol |
|---|---|
| 主要な著者: | , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7718946/ https://ncbi.nlm.nih.gov/pubmed/33099868 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12835 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|